Reassessment of Alzheimer's Drug Raises Hope--and Concerns
Published Date: 12/6/2019
Source: scientificamerican.com
Will the benefits of aducanumab be enough to justify FDA approval, given its small benefit and high price? -- Read more on ScientificAmerican.com